Following is a summary of current health news briefs. Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans. The hard work had paid off, allowing Soriot to clinch the first agreement for a non-U.S. drugmaker and shield his Anglo-Swedish company from threatened steep tariffs on imports to the U.S. – the world's largest pharmaceuticals market. India searches premises of cough syrup maker linked to child deaths, source says India's financial crime-fighting agency is searching seven sites on suspicion of money-laundering by Sresan Pharma, the cough syrup maker linked to the deaths of several children over the last month, a source told Reuters on Monday. At least 19 children died in the central state of Madhya Pradesh after taking the syrup, banned after a test this month showed it contained levels of a toxic chemical, diethylene glycol, that were nearly 500 times the permissible limit.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
